Form 4: Nature's Sunshine Products CEO Terrence Moorehead Reports Stock Transactions
SEC Form 4 Filing
CEO Terrence Moorehead reports acquisition and disposal of Nature's Sunshine Products (NATR) shares related to restricted stock units.
Summary
- Terrence Moorehead, CEO of Nature's Sunshine Products, reported transactions involving the company's common stock.
- On March 10, 2025, he acquired 49,389 shares at a price of $14.74 per share through restricted stock units (RSUs).
- These RSUs vest in three equal annual installments from the initial grant date through March 10, 2028.
- On March 11, 2025, 6,180 shares were disposed of at $14.5 per share to cover tax obligations related to the vesting of RSUs granted on March 11, 2024.
- Following these transactions, Moorehead beneficially owns 552,594 shares of Nature's Sunshine Products.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The transactions are routine and related to executive compensation. There is no indication of unusual activity or concern.
Positives
- The acquisition of shares through RSUs indicates a long-term incentive for the CEO, aligning his interests with the company's performance.
Negatives
- The disposal of shares to cover tax obligations, while common, slightly reduces the CEO's direct stake in the company.
Industry Context
Insider transactions are routinely monitored by investors as they can provide insights into management's perspective on the company's valuation and future prospects. RSU grants are a common form of executive compensation in the industry.
Comparison to Industry Standards
- RSUs are a standard form of equity compensation used across various industries to align executive incentives with shareholder value.
- The vesting schedule of three equal annual installments is also a common practice.
- Comparable companies in the nutritional supplements industry, such as Herbalife Nutrition and USANA Health Sciences, also utilize equity-based compensation for their executives.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders.
- Shareholders may view the RSU grants as a positive incentive for management.
Key Dates
| Date | Description |
|---|---|
| 03/11/2024 | Date of initial grant of restricted stock units. |
| 03/10/2025 | Date of acquisition of 49,389 shares through RSU vesting. |
| 03/11/2025 | Date of disposal of 6,180 shares for tax obligations. |
| 03/12/2025 | Date of signature on the Form 4 filing. |
| 03/10/2028 | Final vesting date for the restricted stock units. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.